Cooperation of bisphenol A and leptin in inhibition of caspase-3 expression and activity in OVCAR-3 ovarian cancer cells

Toxicology in Vitro

Volumn 27, Issue 6, 2013, Pages 1937-1943

  Ptak, Anna ^a   Rak Mardyła, Agnieszka ^a   Gregoraszczuk, Ewa L ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Bisphenol A; Caspase 3; ERK1 2; Leptin; OVCAR 3; STAT3; Survivin

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; CASPASE 3; ESTRADIOL; LEPTIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; STAT3 PROTEIN; SURVIVIN;

APOPTOSIS; ARTICLE; CANCER CELL; CASPASE 3 GENE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME INHIBITION; ESTROGEN ACTIVITY; FEMALE; FLUOROMETRY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MOLECULAR INTERACTION; NUCLEOTIDE SEQUENCE; OVARY CANCER; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

BISPHENOL A; CASPASE-3; ERK1/2; LEPTIN; OVCAR-3; STAT3; SURVIVIN;

BENZHYDRYL COMPOUNDS; CASPASE 3; CASPASE INHIBITORS; CELL LINE, TUMOR; ESTRADIOL; ESTROGENS; ESTROGENS, NON-STEROIDAL; FEMALE; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; JANUS KINASES; LEPTIN; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASES; OVARIAN NEOPLASMS; PHENOLS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-AKT; STAT3 TRANSCRIPTION FACTOR;

EID: 84880667422     PISSN: 08872333     EISSN: 18793177     Source Type: Journal    
DOI: 10.1016/j.tiv.2013.06.017     Document Type: Article

References (51)

1. Ambrosini G., Adida C., Altieri D.C. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat. Med. 1997, 3:917-921.
2. Benachour N., Aris A. Toxic effects of low doses of Bisphenol-A on human placental cells. Toxicol. Appl. Pharmacol. 2009, 241:322-328.
3. Brabant G., Nave H., Mayr B., Behrend M., van Harmelen V., Arner P. Secretion of free and protein-bound leptin from subcutaneous adipose tissue of lean and obese women. J. Clin. Endocrinol. Metab. 2002, 87:3966-3970.
4. Bredhult C., Bäcklin B.M., Olovsson M. Effects of some endocrine disruptors on the proliferation and viability of human endometrial endothelial cells in vitro. Reprod. Toxicol. 2007, 23:550-559.
5. Canesi L., Lorusso L.C., Ciacci C., Betti M., Zampini M., Gallo G. Environmental estrogens can affect the function of mussel hemocytes through rapid modulation of kinase pathways. Gen. Comp. Endocrinol. 2004, 138:58-69.
6. Chen C., Chang Y.C., Liu C.L., Chang K.J., Guo I.C. Leptin-induced growth of human ZR-75-1 breast cancer cells is associated with up-regulation of cyclin D1 and c-Myc and down regulation of tumor suppressor p53 and p21WAF1/CIP1. Breast Cancer Res. Treat. 2006, 98:121-132.
7. Choi J.H., Park S.H., Leung P.C., Choi K.C. Expression of leptin receptors and potential effects of leptin on the cell growth and activation of mitogen-activated protein kinases in ovarian cancer cells. J. Clin. Endocrinol. Metab. 2005, 90:207-210.
8. Dekant W., Völkel W. Human exposure to bisphenol A by biomonitoring: methods, results and assessment of environmental exposures. Toxicol. Appl. Pharmacol. 2008, 228:114-134.
9. Diel P., Olff S., Schmidt S., Michna H. Effects of the environmental estrogens bisphenol A, o, p'-DDT, p-tert-octylphenol and coumestrol on apoptosis induction, cell proliferation and the expression of estrogen sensitive molecular parameters in the human breast cancer cell line MCF-7. J. Steroid. Biochem. Mol. Biol. 2002, 80:61-70.
10. Dong S., Terasaka S., Kiyama R. Bisphenol A induces a rapid activation of Erk1/2 through GPR30 in human breast cancer cells. Environ. Pollut. 2011, 159:212-218.
11. Fernández-Riejos P., Goberna R., Sánchez-Margalet V. Leptin promotes cell survival and activates Jurkat T lymphocytes by stimulation of mitogen-activated protein kinase. Clin. Exp. Immunol. 2008, 151:505-518.
12. Fernando R.I., Wimalasena J. Estradiol abrogates apoptosis in breast cancer cells through inactivation of BAD: ras-dependent nongenomic pathways requiring signaling through ERK and Akt. Mol. Biol. Cell. 2004, 15:3266-3284.
13. Frasor J., Danes J.M., Komm B., Chang K.C., Lyttle C.R., Katzenellenbogen B.S. Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype. Endocrinology 2003, 144:4562-4574.
14. Frühbeck G. Intracellular signalling pathways activated by leptin. Biochem. J. 2006, 393:7-20.
15. Guo Z., Jiang H., Xu X., Duan W., Mattson M.P. Leptin-mediated cell survival signaling in hippocampal neurons mediated by JAK STAT3 and mitochondrial stabilization. J. Biol. Chem. 2008, 283:1754-1763.
16. Ito K., Utsunomiya H., Niikura H., Yaegashi N., Sasano H. Inhibition of estrogen actions in human gynecological malignancies: new aspects of endocrine therapy for endometrial cancer and ovarian cancer. Mol. Cell Endocrinol. 2011, 340:161-167.
17. Jiang H., Yu J., Guo H., Song H., Chen S. Upregulation of survivin by leptin/STAT3 signaling in MCF-7 cells. Biochem. Biophys. Res. Commun. 2008, 368:1-5.
18. Jin Z., El-Deiry W.S. Overview of cell death signaling pathways. Cancer Biol. Therapy 2005, 4:139-163.
19. Kandouz M., Siromachkova M., Jacob D., Chretien Marquet B., Therwath A., Gompel A. Antagonism between estradiol and progestin on Bcl-2 expression in breast-cancer cells. Int. J. Cancer 1996, 68:120-125.
20. Kawasaki H., Altieri D., Lu C., Toyoda M., Tenjo T., Tanigawa N. Inhibition of apoptosis by surviving predicts shorter survival rates in colorectal cancer. Cancer Res. 1998, 58:5071-5074.
21. Lapensee E.W., Tuttle T.R., Fox S.R., Ben-Jonathan N. Bisphenol A at low nanomolar doses confers chemoresistance in estrogen receptor-alpha-positive and -negative breast cancer cells. Environ. Health Perspect. 2009, 117:175-180.
22. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 2001, 25:402-408.
23. Masuno H., Iwanami J., Kidani T., Sakayama K., Honda K. Bisphenol a accelerates terminal differentiation of 3T3-L1 cells into adipocytes through the phosphatidylinositol 3-kinase pathway. Toxicol. Sci. 2005, 84:319-327.
24. Mattioli B., Giordani L., Quaranta M.G., Viora M. Leptin exerts an anti-apoptotic effect on human dendritic cells via the PI3K-Akt signaling pathway. FEBS Lett. 2009, 583:1102-1106.
25. Miyawaki J., Sakayama K., Kato H., Yamamoto H., Masuno H. Perinatal and postnatal exposure to bisphenol a increases adipose tissue mass and serum cholesterol level in mice. J. Atheroscler. Thromb. 2007, 14:245-252.
26. Monzó M., Rosell R., Felip E., Astudillo J., Sánchez J.J., Maestre J., Martín C., Font A., Barnadas A., Abad A. A novel anti-apoptosis gene: reexpression of survivin messenger RNA as a prognosis marker in non-small-cell lung cancers. J. Clin. Oncol. 1999, 17:2100-2104.
27. Nakamura M., Tsuji N., Asanuma K., Kobayashi D., Yagihashi A., Hirata K., Torigoe T., Sato N., Watanabe N. Survivin as a predictor of cis-diamminedichloroplatinum sensitivity in gastric cancer patients. Cancer Sci. 2004, 95:44-51.
28. Newbold R.R., Padilla-Banks E., Jefferson W.N., Heindel J.J. Effects of endocrine disruptors on obesity. Int. J. Androl. 2008, 31:201-208.
29. Newbold R.R., Padilla-Banks E., Jefferson W.N. Environmental estrogens and obesity. Mol. Cell Endocrinol. 2009, 304:84-89.
30. Olsen C.M., Green A.C., Whiteman D.C., Sadeghi S., Kolahdooz F., Webb P.M. Obesity and the risk of epithelial ovarian cancer: a systematic review and meta-analysis. Eur. J. Cancer 2007, 43:690-709.
31. Owecki M., Nikisch E., Miczke A., Pupek-Musialik D., Sowiński J. Leptin, soluble leptin receptors, free leptin index, and their relationship with insulin resistance and BMI: high normal BMI is the threshold for serum leptin increase in humans. Horm. Metab. Res. 2010, 42:585-599.
32. Palianopoulou M., Papanikolaou V., Stefanou N., Tsezou A. The activation of leptin-mediated survivin is limited by the inducible suppressor SOCS-3 in MCF-7 cells. Exp. Biol. Med. (Maywood) 2011, 236:70-76.
33. Perera C.N., Chin H.G., Duru N., Camarillo I.G. Leptin-regulated gene expression in MCF-7 breast cancer cells: mechanistic insights into leptin-regulated mammary tumor growth and progression. J. Endocrinol. 2008, 199:221-233.
34. Pérez-Pérez A., Maymó J., Dueñas J.L., Goberna R., Calvo J.C., Varone C., Sánchez-Margalet V. Leptin prevents apoptosis of trophoblastic cells by activation of MAPK pathway. Arch. Biochem. Biophys. 2008, 477:390-395.
35. Ptak A., Gregoraszczuk E.L. Bisphenol A induces leptin receptor expression, creating more binding sites for leptin, and activates the JAK/Stat, MAPK/ERK and PI3K/Akt signalling pathways in human ovarian cancer cell. Toxicol. Lett. 2012, 210:332-337.
36. Ptak A., Wróbel A., Gregoraszczuk E.L. Effect of bisphenol-A on the expression of selected genes involved in cell cycle and apoptosis in the OVCAR-3 cell line. Toxicol. Lett. 2011, 202:30-35.
37. Ptak A., Kolaczkowska E., Gregoraszczuk E.L. Leptin stimulation of cell cycle and inhibition of apoptosis gene and protein expression in OVCAR-3 ovarian cancer cells. Endocrine 2013, 43:394-403.
38. Rho S.B., Kim B.R., Kang S. A gene signature-based approach identifies thioridazine as an inhibitor of phosphatidylinositol-3'-kinase (PI3K)/AKT pathway in ovarian cancer cells. Gynecol. Oncol. 2011, 120:121-127.
39. Russo V.C., Metaxas S., Kobayashi K., Harris M., Werther G.A. Antiapoptotic effects of leptin in human neuroblastoma cells. Endocrinology 2004, 145:4103-4112.
40. Satyan K.S., Swamy N., Dizon D.S., Singh R., Granai C.O., Brard L. Phenethyl isothiocyanate (PEITC) inhibits growth of ovarian cancer cells by inducing apoptosis: role of caspase and MAPK activation. Gynecol. Oncol. 2006, 103:261-270.
41. Seeger H., Wallwiener D., Kraemer E., Mueck A.O. Comparison of possible carcinogenic estradiol metabolites: effects on proliferation, apoptosis and metastasis of human breast cancer cells. Maturitas 2006, 54:72-77.
42. Sui L., Dong Y., Ohno M., Watanabe Y., Sugimoto K., Tokuda M. Survivin expression and its correlation with cell proliferation and prognosis in epithelial ovaria tumors. Int. J. Oncol. 2002, 21:315-320.
43. Takahashi R., Deveraux Q., Tamm I., Welsh K., Assa-Munt N., Salvesen G.S., Reed J.C. A single BIR domain of XIAP sufficient for inhibiting caspases. J. Biol. Chem. 1998, 273:7787-7790.
44. Takai N., Miyazaki T., Nishida M., Nasu K., Miyakawa I. Expression of survivin is associated with malignant potential in epithelial ovarian carcinoma. Int. J. Mol. Med. 2002, 10:211-216.
45. Tartaglia L.A., Dembski M., Weng X., Deng N., Culpepper J., Devos R., Richards G.J., Campfield L.A., Clark F.T., Deeds J., Muir C., Sanker S., Moriarty A., Moore K.J., Smutko J.S., Mays G.G., Wool E.A., Monroe C.A., Tepper R.I. Identification and expression cloning of a leptin receptor, Ob-R. Cell 1995, 83:1263-1271.
46. Uddin S., Bu R., Ahmed M., Abubaker J., Al-Dayel F., Bavi P., Al-Kuraya K.S. Overexpression of leptin receptor predicts an unfavorable outcome in middle eastern ovarian cancer. Mol. Cancer 2009, 8:74.
47. Vom Saal F.S., Nagel S.C., Coe B.L., Angle B.M., Taylor J.A. The estrogenic endocrine disrupting chemical bisphenol A (BPA) and obesity. Mol. Cell Endocrinol. 2012, 354:74-84.
48. Xu J., Osuga Y., Yano T., Morita Y., Tang X., Fujiwara T., Takai Y., Matsumi H., Koga K., Taketani Y., Tsutsumi O. Bisphenol A induces apoptosis and G2-to-M arrest of ovarian granulosa cells. Biochem. Biophys. Res. Commun. 2002, 292:456-462.
49. Yang X., Fraser M., Moll U.M., Basak A., Tsang B.K. Akt-mediated cisplatin resistance in ovarian cancer: modulation of p53 action on caspase-dependent mitochondrial death pathway. Cancer Res. 2006, 66:3126-3136.
50. Yang J., Wang Y., Gao Y., Shao J., Zhang X.J., Yao Z. Reciprocal regulation of 17beta-estradiol, interleukin-6 and interleukin-8 during growth and progression of epithelial ovarian cancer. Cytokine 2009, 46:382-391.
51. Zhang M., Latham D., Delaney M., Chakravarti A. Survivin mediates resistance to anti-androgen therapy in prostate cancer. Oncogene 2005, 24:2474-2482.